BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1533 related articles for article (PubMed ID: 19249105)

  • 1. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression.
    Fitzgerald PB; Hoy K; McQueen S; Herring S; Segrave R; Been G; Kulkarni J; Daskalakis ZJ
    J Clin Psychopharmacol; 2008 Feb; 28(1):52-8. PubMed ID: 18204341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
    Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
    Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder.
    Kang JI; Kim CH; Namkoong K; Lee CI; Kim SJ
    J Clin Psychiatry; 2009 Dec; 70(12):1645-51. PubMed ID: 19709504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.
    Rossini D; Lucca A; Zanardi R; Magri L; Smeraldi E
    Psychiatry Res; 2005 Nov; 137(1-2):1-10. PubMed ID: 16225930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.
    Brakemeier EL; Wilbertz G; Rodax S; Danker-Hopfe H; Zinka B; Zwanzger P; Grossheinrich N; Várkuti B; Rupprecht R; Bajbouj M; Padberg F
    J Affect Disord; 2008 May; 108(1-2):59-70. PubMed ID: 17963846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression.
    Loo CK; Mitchell PB; McFarquhar TF; Malhi GS; Sachdev PS
    Psychol Med; 2007 Mar; 37(3):341-9. PubMed ID: 17176505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine for treatment-resistant unipolar depression.
    Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
    J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?
    Pallanti S; Bernardi S; Di Rollo A; Antonini S; Quercioli L
    Neuroscience; 2010 May; 167(2):323-8. PubMed ID: 20144692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
    Dell'Osso B; Mundo E; D'Urso N; Pozzoli S; Buoli M; Ciabatti M; Rosanova M; Massimini M; Bellina V; Mariotti M; Altamura AC
    Bipolar Disord; 2009 Feb; 11(1):76-81. PubMed ID: 19133969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
    Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
    Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.